Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Built specifically for peptide protocols.
In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
This is usually less than 1.5 milliliters (mL), but up to 3 mL may be administered into the abdomen
Please note that the FDA does not review supplements
US$ 28.80
US$ 29.61
US$ 28.25
US$ 20.06
US$ 23.76
